References
- Yamamura H. L., Snyder S. H. Muscarinic cholinergic receptor binding in lognitudinal muscle of the guinea pig ileum with (3H)quinuclindinyl benzilate. Mol. Pharmacol. 1974; 10: 861
- Fields J. Z., Roeske W. R., Morkin E., Yamamura H. I. Cardiac Muscarinic Cholenergic Receptors: Biochemical Identification and Characterization. J. Biol. Chem. 1977; 253: 3251
- Levin R. M., Shofer F. S., Wein A. J. Cholinergic, adre-nergic and purinergic response of sequential strips of rabbit urinary bladder. J. Pharmacol. Exp. Ther. 1980; 212: 536
- Anderson G. F., Marks B. H. Spare cholinergic receptors in the urinary bladder. J. Pharmacol. Exp. Ther. 1982; 221: 598
- Nilvebrant L., Sparf B. Muscarinic receptor Binding in the guinea pig urinary bladder. Acta Pharmacol. et toxicol. 1983; 52: 30
- Jaqua-Stewart M. L., Read W. O., Steffen R. P. Isolation of pure myocardial subcellular organelles. Anal. Biochem. 1979; 96: 293
- Batra S. Characterization of 3H-nitrendipine binding to uterine smooth muscle plasma membrane and its relevance to inhibition of calcium entry. Br. J. Pharmac. 1985; 85: 767
- Lowry O. H., Rosenborough N. J., Farr A. L., Randall R. J. Protein measurment with the Folinphenol reagent. J. Biol. Chem. 1951; 193: 265
- Batra S., Bengtsson L. P.H. A highly efficient method for the extraction of progesterone from uterus and its compatibility with subsequent radio-immunoassay. J. Steroid. Biochem. 1976; 7: 599
- Gilbert R. F. T., Hanley M. R., Iversen L. L. 3H-Quinuclidinyl benzilate binding to muscarinic receptors in rat brain: Comparison of results from intact brain slices and homogenates. Br. J. Pharmac. 1979; 65: 451
- Hershkowitz M., Eliash S., Cohen S. The muscarinic cholinergic receptors in the posteroid hypothalamus of hypertensive and normotensive rats. Eur. J. Pharmacol. 1982; 86: 229
- Hammer R., Berrie C. P., Birdsall N. J. M., Burgen A. S.V., Humle E. C. Pirenzipine distinguishes between different subclasses of muscarinic receptors. Nature (London) 1980; 283: 90
- Hammer R., Giachetti. Muscarinic Receptor Sub types: M1 and M2. Biochemical funtional characterization. Life Sciences. 1982; 31: 2991
- U'Prichard D. C., Greenberg D. A., Snyder S. H. Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha-noradrenergic receptors. Mol. Pharmacol. 1977; 13: 454
- Ariens E. J., Beld A. J., Rodrogues de Miranda J. F., Simonis A. M. The Pharmacon - Receptor - Effector Concept. The Receptors: A Comprehensive Treatise. Plenum Press, New York 1980; 66
- Karliner J. S., Motulsky H. J., Dunlop J., Brown J. H., Insel P. A. Verapamil Competitively Inhibits alpha 1-adrenergic and muscarinic but not beta-adrenergic receptors in rat myocardium. J. Cardio-vasc. Pharmacol. 1982; 4: 525
- Danielsson E., Undén A., Bartai T. Orthonavadate includes loss of muscarinic cholonergic binding sites. Bioschem. Biophys. Res. Comm. 1983; 110: 567
- Taft W. C., Jr, Abdel-Latif A. A., Akhtar R. A. (3H) Quinuclindinyl benzelate binding to muscarinic receptors and (3H) WB-4101 binding to alpha-adrenergic receptors in rabbit iris. Biochem. Pharmacol. 1980; 29: 2713